AMIDD 2023 Lecture 1 Offline Activities
Please answer the questions below. Submission deadline: before the 3rd lecture
Sign in to Google to save your progress. Learn more
Email *
Your name
 *
Choose the modalities of the following drugs. In case of doubt, consult the DrugCentral database (https://drugcentral.org/) and/or the Wikipedia
 *
Small molecules
Proteins
Oligonucleotides
Other modalities
Comirnaty (COVID-19 vaccination)
Humira (Adalimumab, anti-TNFalpha)
Keytruda (Pembrolizumab, anti-PD1)
Paxlovid (Ritonavir/Nirmatrelvir)
Spikevax (COVID-19 vaccination)
Eliquis (Apixaban, factor Xa inhibitor)
Biktarvy (cocktail for HIV)
Revlimid (lenalidomide, mutlple myeloma)
Stelara (Ustekinumab, anti-IL12/IL23)
Eylea (Aflibercept, anti-VEGF)
Opdivo (Nivolumab, anti-PD-1)
Dupixent (Dupilumab, anti-IL-4Ralpha)
Ozempic (semaglutide, GLP1 analog)
Jardiance (Empagliflozin, SGLT-2 inhibitor)
What patterns do you observe based on the distribution of modalities, as well as on the indications (given by the color bars below the compounds)?
 *
How would you explain the observations of the patterns?
 *
If you have any questions/comments, please share them here. Thank you.
 *
A copy of your responses will be emailed to the address you provided.
Submit
Clear form
Never submit passwords through Google Forms.
reCAPTCHA
PrivacyTerms
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy
Google Forms